Cleared Traditional

K101089 - EASYRA MICRO-ALBUMIN REAGENT AND CALIBRATOR

K101089 is an FDA 510(k) clearance for EASYRA MICRO-ALBUMIN REAGENT AND CALIBRATOR, manufactured by Medica Corp.. The device is a Class 2 Chemistry device with product code DCF cleared through the Traditional 510(k) pathway after a 450-day FDA review.

K101089 · Medica Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2011
Decision
450d
Days
Class 2
Risk

K101089 is an FDA 510(k) clearance for the EASYRA MICRO-ALBUMIN REAGENT AND CALIBRATOR. Classified as Albumin, Antigen, Antiserum, Control (product code DCF), Class II - Special Controls.

Submitted by Medica Corp. (Bedford, US). The FDA issued a Cleared decision on July 13, 2011 after a review of 450 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 866.5040 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Chemistry submissions.

View all Medica Corp. devices

FDA 510(k) Submission Details - K101089

510(k) Number K101089 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 19, 2010
Decision Date July 13, 2011
Days to Decision 450 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
362d slower than avg
Panel avg: 88d · This submission: 450d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DCF Device Classification - Class 2, Special Controls

Product Code DCF Albumin, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5040
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - DCF Albumin, Antigen, Antiserum, Control

All 32
Devices cleared under the same product code (DCF) and FDA review panel - the closest regulatory comparables to K101089.
Optilite Low Level Albumin Kit
K153560 · The Binding Site Group , Ltd. · Aug 2016
Human Microalbumin kit for use on SPAPLUS
K143118 · The Binding Site Group , Ltd. · May 2015
HUMAN ALBUMIN CSF KIT
K121045 · The Binding Site Group , Ltd. · Jun 2013
TINA-QUANT ALBUMIN GEN 2
K101203 · Roche Diagnostics · Sep 2010
COBAS 8000 MODULAR SERIES ANALYZER
K100853 · Roche Diagnostics Corp. · Sep 2010
K-ASSAY MICROALBUMIN AND K-ASSAY MICROALBUMIN CALIBRATOR
K091486 · Kamiya Biomedical Co. · Apr 2010